- |||||||||| Viraleze (astodrimer intranasal) / Starpharma
Viraleze (Twitter) - Nov 19, 2022
- |||||||||| Viraleze (astodrimer intranasal) / Starpharma
Clinical, Journal: Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial. (Pubmed Central) - Jun 22, 2022 No systemic absorption of astodrimer sodium via the nasal mucosa was detected. Astodrimer sodium nasal spray was well tolerated and is a promising innovation warranting further investigation for nasal administration to potentially reduce infection and spread of community acquired respiratory virus infections.Trial Registration: ACTRN12620001371987, first registered 22-12-2020 (Australia New Zealand Clinical Trials Registry, https://anzctr.org.au/ ).
|